MIR31HG and non-small cell lung carcinoma: Zheng et al. elucidated that the downregulation of MIR31HG depressed the Wnt/β-catenin signalling pathway via the inhibition of GSK3β and β-catenin expression levels but induced p-GSK3β overexpression in NSCLC cells.